A detailed history of Mizuho Securities Usa LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Mizuho Securities Usa LLC holds 21,935 shares of MRNA stock, worth $883,322. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,935
Previous 3,397 545.72%
Holding current value
$883,322
Previous $227,000 545.37%
% of portfolio
0.03%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$63.64 - $125.14 $1.18 Million - $2.32 Million
18,538 Added 545.72%
21,935 $1.47 Million
Q3 2024

Nov 06, 2024

SELL
$63.64 - $125.14 $1.42 Million - $2.79 Million
-22,313 Reduced 86.79%
3,397 $227,000
Q2 2024

Jul 31, 2024

BUY
$101.21 - $166.61 $2.6 Million - $4.28 Million
25,710 New
25,710 $3.05 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mizuho Securities Usa LLC Portfolio

Follow Mizuho Securities Usa LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Securities Usa LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Securities Usa LLC with notifications on news.